Download by
Scanning QR Code
No Stock Yet
*ST Blue Shield (300297.SZ): Controlling shareholders who reduced their holdings by more than half passively reduced their holdings by 0.95%
Gelonghui, March 20, 丨*ST. Blue Shield (300297.SZ) announced that the company recently received a “Notice Letter” from the controlling shareholder Ke Zongqing. As of the announcement disclosure date, the number of holdings reduction planned this time had already exceeded half. Ke Zongqing passively reduced his holdings by 11.8302 million shares, a reduction ratio of 0.95%.
*ST Blue Shield (300297.SZ): 11.826,400 shares held by the controlling shareholder will be judicially auctioned
Gelonghui, Feb. 22丨*ST Blue Shield (300297.SZ) announced that recently, the company received a notice from the controlling shareholder Ke Zonggui and learned through an inquiry to the Taobao Judicial Auction Online Platform that Ke Zonggui's 11.8263.9 million shares of the company will be judicially auctioned. The number of shares involved this time was 11.8263.9 million shares, accounting for 12.42% of Ke Zonggui's shares and 0.95% of the company's total share capital.
Changes in A-shares | *ST Blue Shield plummeted 15%, leading the decline, the revised performance forecast predicts an annual loss of more than 1.1 billion yuan
Gelonghui, Feb. 17 丨*ST. Blue Shield (300297.SZ) fell to a standstill (20%). It is now reported that 1.29 yuan fell more than 15%, ranking first in the market decline, with a total market capitalization of less than 2 billion yuan. According to the company's revised performance forecast, it is estimated that the net profit attributable to shareholders of listed companies in 2022 will be a loss of 1,100 million yuan to 1,200 million yuan, and net profit after deducting non-recurring profit and loss will be a loss of 950 million yuan to 1,050 million yuan. Furthermore, the controlling shareholder Ke Zongqing plans to passively reduce his share holdings by no more than 1.28%.
*ST Blue Shield (300297.SZ) revises performance forecast: 2022 forecast loss of 1.1 billion yuan to 1.2 billion yuan
Gelonghui, Feb. 17丨*ST. Blue Shield (300297.SZ) disclosed the revised 2022 annual performance forecast announcement. Before the revision, the company expects net profit attributable to shareholders of listed companies in 2022 to be a loss of 900 million yuan to 1,100 million yuan, and net profit after deducting non-recurring profit and loss is a loss of 850 million yuan to 1,050 million yuan; after the revision, the company expects net profit attributable to shareholders of listed companies in 2022 to be a loss of 1,100 million yuan to 1,200 million yuan, and net profit after deducting non-recurring profit and loss is a loss of 950 million yuan to 1,050 million yuan
*ST Blue Shield (300297.SZ): Controlling shareholder Ke Zongqing plans to passively reduce shares by no more than 1.28%
Gelonghui, Feb. 15 丨*ST Blue Shield (300297.SZ) announced that Ke Zongqing, the controlling shareholder and actual controller of 6.5 7% of the shares, plans to passively reduce the company's shares by 159.63861 million shares through centralized bidding within 6 months from the date of disclosure of the holdings reduction plan announcement, that is, no more than 1.28% of the company's total share capital.
*ST Blue Shield (300297.SZ): 6.56% of Shenzhen Boyi's shares will be judicially auctioned
Gelonghui, Feb. 10, 丨*ST. Blue Shield (300297.SZ) announced that recently, by searching the Taobao judicial auction online platform, the company learned that 81.91 million shares of the company held by Shenzhen Boyi, a shareholder holding 5% or more of the company's shares (accounting for 86.77% of its shares, or 6.56% of the company's total share capital) will be judicially auctioned from 10:00 on February 21, 2023 to 10:00 on February 22, 2023 (excluding delays); the reason was a judicial ruling.
*ST Blue Shield (300297.SZ): 31.28 million shares held by the controlling shareholder will be judicially auctioned
Gelonghui, Feb. 6, 丨*ST. Blue Shield (300297.SZ) announced that the company recently received a notice from the controlling shareholder Ke Zongqing and learned that the 31,279997 million shares of the company held by Ke Zongqing will be judicially auctioned, accounting for 38.12% of its shares and 2.50% of the company's total share capital.
*ST Blue Shield (300297.SZ): Shenzhen Boyi, the shareholder holding 7.5552% of the shares, plans to passively reduce its shareholding by 1%
Gelonghui, Feb. 2, 丨*ST. Blue Shield (300297.SZ) announced that the company's 7.5552% shareholder, Shenzhen Boyi, plans to passively reduce the company's shares by 12.49 million shares through centralized bidding within 3 months after 15 trading days from the date of disclosure of this holdings reduction plan announcement, accounting for 1% of the company's total share capital.
*ST Blue Shield (300297.SZ) has a projected loss of 900 million to 1.1 billion yuan in 2022
Gelonghui, Feb. 1, 丨*ST. Blue Shield (300297.SZ) announced that the estimated net loss attributable to shareholders of listed companies in 2022 was 900 million yuan to 1.1 billion yuan, compared to a loss of 155.1675 million yuan for the same period last year; net loss after deducting non-recurring profit and loss was 850 million yuan to 1.05 billion yuan, compared to a loss of 154,0468,500 million yuan for the same period last year. The reasons for the change in performance are as follows: 1. During the reporting period, due to factors such as insufficient liquidity, the company's daily production and operation were greatly adversely affected. The company continued to experience matters such as overdue debts, lawsuits, and inclusion of untrustworthy executees one after another
*ST Blue Shield (300297.SZ) forecasted a loss, with an estimated net loss of 900 million yuan to 1.1 billion yuan in 2022
According to the Zhitong Finance App, *ST Blue Shield (300297.SZ) disclosed its 2022 annual results forecast. The company expects net loss attributable to shareholders of listed companies of 900 million yuan to 1.1 billion yuan; net loss after deducting non-recurring profit and loss is 850 million yuan to 1.05 billion yuan.
Loading...
No Stock Yet